Physician

Laura F Mcclure Barnes, M.D.

According to 2025 Medicare claims, Laura Barnes, M.D. (NPI: 1629094438) practices hematology/oncology in the Nashville-Davidson--Murfreesboro--Franklin, TN market, with the plurality of this provider's patient population coming from Sumner, TN. This provider's primary affiliated billing organization is TENNESSEE ONCOLOGY PLLC (NPI: 1811955917; TIN: 621647259) and primary practice location at 37075-2379.

Barnes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 464 traditional Medicare patients, billed 127,042 HCPCS/CPT codes, and received $1,832,683 in Medicare payments. The top billing code was 82728 (Ferritin (blood protein) level). Part D data shows 1,007 prescription claims across 223 beneficiaries totaling $2,825,765 in drug costs, led by Revlimid (Lenalidomide). 2021 DME data shows 80 claims. Open Payments data shows 20 records totaling $408. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $709,710 to $1,832,683. Similarly, Part D prescription costs have risen steadily, from $576,164 to $2,825,765. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	312	105,139	$709,710
2016	318	144,744	$782,405
2017	338	113,902	$874,929
2018	309	84,103	$853,745
2019	377	139,125	$1,148,987
2020	373	169,625	$1,936,882
2021	429	166,232	$1,646,985
2022	420	180,988	$1,571,795
2023	451	182,774	$1,574,958
2024	464	127,042	$1,832,683

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	133	941	$576,164
2016	163	1,187	$1,002,033
2017	172	1,161	$1,831,774
2018	149	817	$1,434,429
2019	135	675	$1,418,901
2020	160	798	$1,445,717
2021	164	850	$1,636,044
2022	196	1,091	$2,007,491
2023	206	957	$2,324,582
2024	223	1,007	$2,825,765

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	36	$830
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	80	$5,468
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
82728	Ferritin (blood protein) level	220	464	$13
80053	Blood test, comprehensive group of blood chemicals	411	1,074	$10
36415	Insertion of needle into vein for collection of blood sample	432	1,438	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	407	1,486	$8
83540	Iron level	213	442	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Revlimid	Lenalidomide	59	1,652	$926,870
Imbruvica	Ibrutinib	28	792	$428,805
Jakafi	Ruxolitinib Phosphate	39	1,170	$323,078
Ibrance	Palbociclib	19	420	$217,371
Calquence	Acalabrutinib Maleate	14	420	$211,770

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	20	$408	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura F. Mcclure Barnes, M.D.?

Tedicare shows public-source Medicare data for Laura F. Mcclure Barnes, M.D. (NPI 1629094438), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura F. Mcclure Barnes, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura F. Mcclure Barnes, M.D.?

Laura F. Mcclure Barnes, M.D. is linked to TENNESSEE ONCOLOGY PLLC (billing NPI 1811955917) in the available physician profile data.

Does Laura F. Mcclure Barnes, M.D. have Open Payments data?

Laura F. Mcclure Barnes, M.D. has 20 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.